Targeted Muscle Reinnervation Treats Neuroma and Phantom Pain in Major Limb Amputees: A Randomized Clinical Trial.
Gregory A Dumanian, Benjamin K Potter, Lauren M Mioton...
https://pubmed.ncbi.nlm.nih.gov/30371518/Actively Recruiting
Led by Prometei Pain Rehabilitation Center · Updated on 2025-01-09
110
Participants Needed
9
Research Sites
156 weeks
Total Duration
This research aims to compare the effectiveness of three surgical methods for reducing residual limb pain, neuroma pain, and phantom limb pain in people who have had a major limb amputation. These types of pain fall under the category of postamputation pain, which can have different causes requiring specific treatments. The trial is a multi-center, double-blind, randomized controlled study conducted at nine hospitals across seven countries, involving 110 participants. The study will follow participants for up to four years to observe how pain changes after surgery. The three surgical treatments being studied are Targeted Muscle Reinnervation TMR, Regenerative Peripheral Nerve Interface RPNI, and standard neuroma treatment involving neuroma excision and muscle burying. Each surgery takes place in a hospital, lasting about 1 to 3 hours depending on the method. TMR involves rerouting injured nerves to nearby motor nerves RPNI involves splitting the nerve into fascicles and wrapping them in muscle grafts the standard treatment removes the painful neuroma and buries the nerve in nearby muscle tissue. Participants are randomly assigned to one of these treatments in equal groups. Participants will be followed up at 1, 3, 6, and 12 months after surgery, and again at 2 and 4 years to assess pain levels. Questionnaires previously used in clinical settings will measure residual limb pain, neuroma pain, and phantom limb pain intensity. After 12 months, participants and evaluators will learn which treatment was given, and those unhappy with results can discuss alternative treatments with their clinical investigator. The primary outcome measured is residual limb pain intensity from baseline to 12 months post-surgery, with secondary measures including neuroma and phantom limb pain intensities over the same period.
CONDITIONS
Surgical Treatments for Postamputation Pain
M
Max Ortiz Catalan, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Prometei Pain Rehabilitation Center
Lead Sponsor
Vastra Gotaland Region
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Targeted Muscle Reinnervation (TMR) | Regenerative Peripheral Nerve Interface (RPNI) | Standard Neuroma Treatment (Excision and Muscle Burying) |
|---|---|---|---|
| What is it? | A surgical procedure redirecting cut nerve endings into nearby motor nerves of unused muscle, aiming to reduce neuroma formation and phantom limb pain. | A surgical method where split nerve fascicles are wrapped in free muscle grafts to provide a biological target for nerve regrowth, aiming to prevent painful neuroma and reduce pain. | The conventional approach involves excising the neuroma and burying the nerve stump within adjacent muscle, aiming to shield the nerve from mechanical irritation. |
| Role in the study | One of the trial’s active comparator arms; participants are randomized to receive TMR. | One of the trial’s active comparator arms; participants are randomized to undergo RPNI. | Serves as the conventional surgical comparator and one of the actual trial arms; participants receive standard neuroma excision and muscle burying. |
| Primary use | Aimed at reducing postamputation limb pain, including residual and phantom limb pain, through advanced nerve handling at the time of neuroma excision. | Designed to prevent and decrease postamputation neuroma pain and related symptoms by providing a muscle graft interface for severed nerves. | Intended to relieve neuroma pain by physically removing the neuroma and protecting the nerve end within muscle tissue. |
| How is it performed? | During surgery, cut nerve ends are redirected to the motor nerves of an otherwise unused muscle to provide a new target for regrowth. | Surgeons split the severed nerve into smaller bundles (fascicles), each of which is wrapped in a free muscle graft from the patient. | The neuroma is excised and the nerve stump is surgically buried within an adjacent deep muscle to protect it from irritation. |
| Evidence status | TMR has randomized trial evidence and retrospective studies indicating reduction in postamputation neuroma and phantom limb pain in amputees. | Preliminary clinical and pilot studies support RPNI’s use for reducing neuroma-related pain, but large-scale outcomes data are less established compared to TMR. | Longstanding conventional approach with variable effectiveness; pain recurrence (neuroma formation, persisting pain) is reported after this technique. |
| Important limitations | As a more complex procedure, TMR may require additional operative time, technical expertise, and perioperative resources compared to standard excision. | Current evidence for RPNI is from smaller pilot studies or early clinical data; long-term, large-scale outcome data are still emerging. | Pain recurrence is common following neuroma excision and muscle burying, indicating limitations in durability for pain reduction. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo one of three surgical treatments for postamputation pain in a hospital setting.
1 visit (in-person, surgery day)
Duration - 12 months
Participants are monitored to assess pain intensity and recovery after surgery through scheduled follow-up visits.
4 visits at 1, 3, 6, and 12 months post-surgery
Duration - Up to 4 years
Participants continue to be observed for long-term outcomes related to pain up to four years after surgery.
2 visits at 2 and 4 years post-surgery
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Gregory A Dumanian, Benjamin K Potter, Lauren M Mioton...
https://pubmed.ncbi.nlm.nih.gov/30371518/Emily Pettersen, Paolo Sassu, Carina Reinholdt...
https://pubmed.ncbi.nlm.nih.gov/37131180/Carrie A Kubiak, Stephen W P Kemp, Paul S Cederna...
https://pubmed.ncbi.nlm.nih.gov/31461024/Jason M Souza, Jennifer E Cheesborough, Jason H Ko...
https://pubmed.ncbi.nlm.nih.gov/24562875/Emily Pettersen, Paolo Sassu, Francesca Alice Pedrini...
https://pubmed.ncbi.nlm.nih.gov/38526122/Brian L Chang, Josh Mondshine, Christopher E Attinger...
https://pubmed.ncbi.nlm.nih.gov/34398088/Emily Pettersen, Paolo Sassu, Francesca Alice Pedrini...
https://pubmed.ncbi.nlm.nih.gov/38557950/Shoshana L Woo, Theodore A Kung, David L Brown...
https://pubmed.ncbi.nlm.nih.gov/28293490/Kim A Bjorklund, John Alexander, Kirsten Tulchin-Francis...
https://pubmed.ncbi.nlm.nih.gov/37063502/Ian L Valerio, Gregory A Dumanian, Sumanas W Jordan...
https://pubmed.ncbi.nlm.nih.gov/30634038/Prometei Pain Rehabilitation Center
Lead Sponsor
Vastra Gotaland Region
Collaborating Sponsor